deferiprone has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguirre, P | 1 |
| Mena, NP | 1 |
| Carrasco, CM | 1 |
| Muñoz, Y | 1 |
| Pérez-Henríquez, P | 1 |
| Morales, RA | 1 |
| Cassels, BK | 1 |
| Méndez-Gálvez, C | 1 |
| García-Beltrán, O | 1 |
| González-Billault, C | 1 |
| Núñez, MT | 1 |
1 other study available for deferiprone and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,2'-Dipyridyl; Animals; Antioxidants; Deferiprone; De | 2015 |